17/07/2017 13:30:00

Sonendo® 2017 Red Herring Top 100 North America Winner In Medical Device Category

LAGUNA HILLS, Calif., July 17, 2017 (GLOBE NEWSWIRE) -- Sonendo®, Inc., announced today it has been named one of the winners of the Red Herring Top 100 North America 2017, recognizing the continent’s most exciting and innovative private technology companies.

Companies were judged by industry experts, insiders, and journalists on a wide variety of criteria including financial performance, innovation, business strategy and market penetration. Winners of verticals, from fintech and marketing to security and IoT.

Red Herring’s editors have been evaluating the world’s startups and tech companies for over two decades. It gives them the ability to see through the industry’s hype to pick firms that will continue on a trajectory to success. Brands such as Alibaba, Google, Kakao, Skype, Spotify, Twitter, and YouTube have all been singled out in Red Herring’s storied history.

“2017’s crop of Top 100 winners has been among our most intriguing yet,” said Red Herring chairman Alex Vieux. “North America has led the way in tech for so many years, and to see such unique, pioneering entrepreneurs and companies here in California, which is in many ways the heartland of the industry, has been a thrilling experience.

“What has excited me most is to see so many people forging niches in high-tech and cutting edge sectors,” added Vieux. “Some of the technical wizardry and first-rate business models showcased here at the conference has been fantastic to learn about. We believe Sonendo embodies the drive, skill, and passion on which tech thrives. Sonendo should be proud of its achievement - the competition was incredibly strong.”

Following Sonendo’s Top 100 win, they are invited to the next step, which is to present at the Top 100 Global event in November that will encompass the best-in-show from the Top 100 Europe, North America, and Asia. Red Herring is dedicated to supporting Sonendo’s continued path to success and innovation.

About the event, President & CEO of Sonendo, Bjarne Bergheim said, “It is an honor for Sonendo to be chosen as a Red Herring Top 100 North America Winner and we look forward to participating in the Top 100 Global event in November.”

About 

Sonendo

Sonendo, Inc. is a privately-held, venture-backed company developing innovative and disruptive technologies to transform dentistry by Saving Teeth Through Sound Science®.  The first commercially available product from Sonendo, the GentleWave® System, available in the US, shows significant improvements in clinical efficacy, and treatment efficiency when compared to standard root canal techniques1-2.  For more information, please visit www.sonendo.com.

1

Sigurdsson A et al.

(2016) J Endod. 42:1040-48. 2Molina B et al.

(2015) J Endod. 41:1701-05.

Forward-Looking Statements

This announcement contains forward-looking statements based on management's beliefs, assumptions, and expectations and information currently available to management.  All statements that address events or developments that we expect or anticipate will occur in the future are forward-looking statements, including without limitation our expectations on the timing and progress of research and development activities.  Management believes that these forward-looking statements are reasonable as and when made.  However, you should not place undue reliance on forward-looking statements because they speak only as of the date when made.  Sonendo does not assume any obligation to update or revise any forward-looking statements publicly, whether as a result of new information, future events or otherwise.  Actual results, developments or events could differ materially from those disclosed in the forward-looking statements.

Media Contact:

Bob Guyatt

Vice President of Marketing

949.766.3636

Primary Logo

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
22 Jul
BAVA
Er der rigtigt forstået, at vi venter på at flere i forsøget skal dø før vi kan se på resultatet?   ..
51
21 Jul
FING-B
Du er overalt. Du skriver i Fingersprint trådene og opretter derefter ny tråd med samme indhold. Nu ..
45
23 Jul
BAVA
Spændende og meget relevante spørgsmål Pits.   Vi har indtil nu nået de første to analysetidspunkte..
25
25 Jul
FING-B
I dag hvor Finger er under et mindre pres er det vigtigt at man holder fast i sin strategi og spørg ..
22
26 Jul
PNDORA
Jeg undrer mig over at nogle få overhovedet gider at forholde sig til hvad GW skriver, han er en Tro..
19
23 Jul
BAVA
Gode spørgsmål!   Ja, der er en klar sammenhæng mellem tilvalg/fravalg af behandling indenfor prosta..
15
22 Jul
NOVO-B
Stærk analyse.  
14
26 Jul
PNDORA
Haha du sidder stadig der og skriger ovre i hjørnet.......mens vi andre har nydt ferien....Bliver du..
13
08:12
BAVA
Bavarian Nordic har udvidet sin partneraftale med Janssen, så den også omfatter vaccineudviklingspro..
12
26 Jul
PNDORA
Det er yderst sjældent, at KongSmart har behov for at hovere her på EI, men kan i huske, at han i fo..
12

Alliance Trust PLC : Transaction in Own Shares

27/07/2017 07:01:20
27 July 2017  Alliance Trust PLC TRANSACTION IN OWN SHARES  The Board of Alliance Trust PLC ("the Company") announces that on 26 July 2017 the Company purchased for cancellation 512,225 ordinary shares of 2.5p each at a price of 719.1805p per share.  Therefore, the total number of voting rights in the Company is now 351,675,897.    The above figure (351,675,897) may be used by shareholder..

P. Schoenfeld Asset Management LLP : Form 8.3 - Booker Group plc

26/07/2017 15:00:06
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: P. Schoenfeld Asset Management LLP (b) Owner or..

Alliance Trust PLC : Net Asset Value(s)

26/07/2017 12:50:03
ALLIANCE TRUST PLC                                    At the close of business on Tuesday 25 July 2017: The Company's NAV per ordinary share, valued on a bid price basis with Debt at Par, was -       excluding income, 759.9p -       including income, 768.5p  The Company's NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was -       excluding income..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Intellipharmaceutics Provides Update on FDA Advisory Committees Meeting for Rexista™ (oxycodone hydrochloride extended release), an Abuse-Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain
2
Pacira Announces Publication of Phase 4 Study of EXPAREL in Patients Undergoing Total Knee Replacement in The Journal of Arthroplasty
3
ATX Seed Ventures Awarded 2017 INNOVATION Award by China-US Chamber of Commerce
4
California Organic Dairy Farmer Out-Innovates Tesla with First Full-Scale Electric Truck
5
Northfield Bancorp, Inc. Announces Second Quarter 2017 Results

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Interactive Data.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
27 July 2017 09:43:13
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20170720.2 - EUROWEB5 - 2017-07-27 10:43:13 - 2017-07-27 09:43:13 - 1000 - Website: OKAY